These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Strategic rethink for German biotechnology. Fernandes M; Miska D Nat Biotechnol; 2002 Oct; 20(10):970-1. PubMed ID: 12355106 [No Abstract] [Full Text] [Related]
27. The Canadian Regenerative Medicine and Nanomedicine Enterprise (CARMENE). Fenniri H Int J Nanomedicine; 2006; 1(3):225-7. PubMed ID: 17717963 [No Abstract] [Full Text] [Related]
28. Bio-Vision 2016: the second national framework plan for biotechnology promotion in Korea. Hyeon BH; Kim HY; Lee CM; Moon SH; Kim ES; Lee SY Biotechnol J; 2008 May; 3(5):591-600. PubMed ID: 18446865 [No Abstract] [Full Text] [Related]
29. European research infrastructures for the development of nanobiotechnologies. Péro H; Faure JE Trends Biotechnol; 2007 May; 25(5):191-4. PubMed ID: 17368840 [TBL] [Abstract][Full Text] [Related]
30. Germany: financing innovation is the future challenge. Schmitt JM Med Device Technol; 2004 Jun; 15(5):38-9. PubMed ID: 15285489 [TBL] [Abstract][Full Text] [Related]
31. Giving your spinout the right spin. McElroy D Nat Biotechnol; 2003 Jul; 21 Suppl():BE39-41. PubMed ID: 12874978 [No Abstract] [Full Text] [Related]
32. Bioengineering and translational research. Kim Y IEEE Eng Med Biol Mag; 2005; 24(2):5. PubMed ID: 15825837 [No Abstract] [Full Text] [Related]
33. South Africa--blazing a trail for African biotechnology. Motari M; Quach U; Thorsteinsdóttir H; Martin DK; Daar AS; Singer PA Nat Biotechnol; 2004 Dec; 22 Suppl():DC37-41. PubMed ID: 15583683 [No Abstract] [Full Text] [Related]
34. Switzerland's medical technology potential. Med Device Technol; 2004 Mar; 15(2):41-2. PubMed ID: 15154339 [TBL] [Abstract][Full Text] [Related]
35. Indian biotechnology--rapidly evolving and industry led. Kumar NK; Quach U; Thorsteinsdóttir H; Somsekhar H; Daar AS; Singer PA Nat Biotechnol; 2004 Dec; 22 Suppl():DC31-6. PubMed ID: 15583682 [No Abstract] [Full Text] [Related]
36. South Korean biotechnology--a rising industrial and scientific powerhouse. Wong J; Quach U; Thorsteinsdóttir H; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC42-7. PubMed ID: 15583684 [No Abstract] [Full Text] [Related]
37. The emergence of Egyptian biotechnology from generics. Abdelgafar B; Thorsteinsdóttir H; Quach U; Singer PA; Daar AS Nat Biotechnol; 2004 Dec; 22 Suppl():DC25-30. PubMed ID: 15583680 [No Abstract] [Full Text] [Related]
38. Chasing biotech, state by state--winners and losers. Wilan KH Nat Biotechnol; 2005 Feb; 23(2):175-9. PubMed ID: 15696143 [No Abstract] [Full Text] [Related]
39. The Netherlands innovation utilising. Med Device Technol; 2008 Sep; 19(5):58-9. PubMed ID: 18947153 [No Abstract] [Full Text] [Related]
40. University spin-offs: opportunity or challenge? Peng X Nat Mater; 2006 Dec; 5(12):923-5. PubMed ID: 17139301 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]